Sei Investments CO Collegium Pharmaceutical, Inc Transaction History

Sei Investments CO

$69 Billion
Q2 2024

A detailed history of Sei Investments CO transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Sei Investments CO holds 9,498 shares of COLL stock, worth $363,393. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,498

Previous 20,329 53.28%

Holding current value

$363,393

Previous $789,000 61.34%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$31.36 - $39.99 $339,660 - $433,131	-10,831 Reduced 53.28%	9,498 $305,000
Q1 2024 May 07, 2024	SELL	$31.23 - $40.91 $3.41 Million - $4.47 Million	-109,212 Reduced 84.31%	20,329 $789,000
Q4 2023 Feb 14, 2024	SELL	$21.16 - $30.8 $96,637 - $140,663	-4,567 Reduced 3.41%	129,541 $3.99 Million
Q3 2023 Nov 14, 2023	SELL	$21.23 - $24.28 $278,282 - $318,262	-13,108 Reduced 8.9%	134,108 $3 Million
Q2 2023 Aug 11, 2023	SELL	$21.06 - $24.0 $228,606 - $260,520	-10,855 Reduced 6.87%	147,216 $3.16 Million
Q1 2023 May 12, 2023	BUY	$23.0 - $29.88 $478,285 - $621,354	20,795 Added 15.15%	158,071 $3.79 Million
Q4 2022 Feb 10, 2023	SELL	$16.14 - $23.55 $13,509 - $19,711	-837 Reduced 0.61%	137,276 $3.18 Million
Q3 2022 Nov 14, 2022	SELL	$15.46 - $20.1 $84,798 - $110,248	-5,485 Reduced 3.82%	138,113 $2.21 Million
Q2 2022 Aug 15, 2022	SELL	$14.22 - $20.88 $159,363 - $234,002	-11,207 Reduced 7.24%	143,598 $2.54 Million
Q1 2022 May 13, 2022	BUY	$17.2 - $22.5 $8,720 - $11,407	507 Added 0.33%	154,805 $3.15 Million
Q4 2021 Feb 14, 2022	BUY	$17.5 - $21.35 $2.7 Million - $3.29 Million	154,298 New	154,298 $2.88 Million
Q3 2021 Nov 12, 2021	SELL	$17.75 - $25.39 $155,667 - $222,670	-8,770 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$19.25 - $26.1 $30,607 - $41,499	-1,590 Reduced 15.35%	8,770 $208,000
Q4 2020 Feb 08, 2021	SELL	$17.83 - $22.29 $829,772 - $1.04 Million	-46,538 Reduced 81.79%	10,360 $208,000
Q3 2020 Nov 06, 2020	BUY	$15.78 - $20.82 $136,844 - $180,551	8,672 Added 17.98%	56,898 $1.18 Million
Q2 2020 Aug 17, 2020	BUY	$15.49 - $23.51 $747,020 - $1.13 Million	48,226 New	48,226 $842,000
Q2 2020 Aug 11, 2020	SELL	$15.49 - $23.51 $608,261 - $923,190	-39,268 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$13.89 - $25.45 $545,432 - $999,370	39,268 New	39,268 $639,000
Q2 2019 Aug 14, 2019	SELL	$10.62 - $16.59 $45,464 - $71,021	-4,281 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$13.58 - $18.72 $194,642 - $268,313	-14,333 Reduced 77.0%	4,281 $62,000
Q4 2018 Feb 13, 2019	BUY	$14.78 - $19.68 $274,405 - $365,378	18,566 Added 38679.17%	18,614 $316,000
Q3 2018 Nov 08, 2018	BUY	$14.16 - $24.3 $679 - $1,166	48 New	48 $0

Others Institutions Holding COLL

# of Institutions

236

Shares Held

39.4M

Call Options Held

84.2K

Put Options Held

18.6K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.31B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Collegium Pharmaceutical, Inc Transaction History